Literature DB >> 1577286

A comparison of five methods for estimating general glaucomatous visual field depression.

A Funkhouser1, J Flammer, F Fankhauser, H P Hirsbrunner.   

Abstract

The separation of local and diffuse visual field loss is important for evaluating the nature and extent of glaucomatous visual field damage. Here, five automated methods for estimating diffuse loss in glaucomatous visual fields (as measured with the Octopus G1 program) are compared. Four are taken from the published literature, and one is introduced in this investigation. It is shown that the new index (here called diffuse loss) provides the best agreement with a value determined using a more empirical approach.

Entities:  

Mesh:

Year:  1992        PMID: 1577286     DOI: 10.1007/bf00164644

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

1.  Evaluating human and automated interpretation of visual field data in perimetry.

Authors:  H P Hirsbrunner; F Fankhauser; A T Funkhouser; A Jenni
Journal:  Jpn J Ophthalmol       Date:  1990       Impact factor: 2.447

2.  Lack of diffuse loss of differential light sensitivity in early glaucoma.

Authors:  A Heijl
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-08

3.  Evaluating a perimetric expert system: experience with Octosmart.

Authors:  H P Hirsbrunner; F Fankhauser; A Jenni; A Funkhouser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 4.  Computerized perimetry in glaucoma management.

Authors:  A Heijl
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-02

5.  Visual field change in low-tension glaucoma over a five-year follow-up.

Authors:  R E Gliklich; W C Steinmann; G L Spaeth
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

6.  The concept of visual field indices.

Authors:  J Flammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

7.  Diffuse and localized nerve fiber loss in glaucoma.

Authors:  P J Airaksinen; S M Drance; G R Douglas; D K Mawson; H Nieminen
Journal:  Am J Ophthalmol       Date:  1984-11       Impact factor: 5.258

8.  Quantification of glaucomatous visual field defects with automated perimetry.

Authors:  J Flammer; S M Drance; L Augustiny; A Funkhouser
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-02       Impact factor: 4.799

9.  Early foveal involvement and generalized depression of the visual field in glaucoma.

Authors:  J L Anctil; D R Anderson
Journal:  Arch Ophthalmol       Date:  1984-03

10.  Is there general reduction of sensitivity in glaucoma?

Authors:  C T Langerhorst; T J van den Berg; E L Greve
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

View more
  6 in total

1.  Problems related to diffuse versus localized loss in the perimetry of glaucomatous visual fields.

Authors:  A T Funkhouser; F Fankhauser; R A Weale
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  A novel strategy for the estimation of the general height of the visual field in patients with glaucoma.

Authors:  Iván Marín-Franch; William H Swanson; Victor E Malinovsky
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-18       Impact factor: 3.117

Review 3.  Contributions to Progress in Ophthalmology from Switzerland: From the 16th to the 21st Century.

Authors:  Ronald D Gerste
Journal:  Ophthalmologica       Date:  2020-08-24       Impact factor: 3.250

4.  The influence of induced forward light scatter on the normal blue-on-yellow perimetric profile.

Authors:  I D Moss; J M Wild
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-07       Impact factor: 3.117

5.  A new diffuse loss index for estimating general glaucomatous visual field depression.

Authors:  A T Funkhouser
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

Review 6.  The discovery of the Flammer syndrome: a historical and personal perspective.

Authors:  Josef Flammer; Katarzyna Konieczka
Journal:  EPMA J       Date:  2017-05-22       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.